Keywords: alemtuzumab, daclizumab, dimethyl fumarate, disease modifying treatment, fingolimod,
glatiramer acetate, interferon beta, laquinimod, MCDONALD Criteria, multiple sclerosis, natalizumab,
teriflunomide
Keywords: alemtuzumab, daclizumab, dimethyl fumarate, disease modifying treatment, fingolimod,glatiramer acetate, interferon beta, laquinimod, MCDONALD Criteria, multiple sclerosis, natalizumab,teriflunomide
การแปล กรุณารอสักครู่..